Analysis
Measuring the return from pharmaceutical innovation 2024
Our latest report looks at the current state of R&D returns for 20 leading biopharma companies; how to streamline clinical trials, optimize pipeline value, and leverage AI and analytics to boost productivity & ROI.
Our latest report looks at the current state of R&D returns for 20 leading biopharma companies; how to streamline clinical trials, optimize pipeline value, and leverage AI and analytics to boost productivity and ROI.
Dive into the report